- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 34.19M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $608.15M |
| Long Term Debt | Q1 2025 · Mar 31, 2024 | $556.17M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $166.61M |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $10.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.37B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.28B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.73B |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $1.08B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.52B |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $1.79B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.85B |
| Current Assets | Q1 2025 · Mar 31, 2024 | $2.21B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.12B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $3.26B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 34.24M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $6.52M |
| Capex | Q1 2025 · Mar 31, 2024 | $26.78M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$239.63M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.16 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.16 |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.58M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $128.32M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.59B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $341.43M |